The latest trading day saw Medtronic (MDT) settling at $87.72, representing a -0.45% change from its previous close.

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.

The blackout was front page news even before the child’s death was known. Newspaper coverage, including from the Pioneer ...

According to the evidence presented at trial, Doron Tavlin learned about a secret, pending acquisition by Medtronic of Mazor ... argued for a period of home confinement and community service.

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Ping An Healthcare and Technology Company Limited established a strategic partnership with Medtronic (MDT) Management Co., Ltd. at the 7th ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

DexCom's Q3 results showed disappointing 2% revenue growth and a 26% decline in operating income. Click here to read my DXCM ...